Stryker is a key player in the hip and knee orthopedic surgical robot device markets, which was valued at $84 billion in 2015, as found in a study, "Hip and Knee Orthopedic Surgical Robot Market Shares, Strategy, and Forecasts, Worldwide, 2016 to 2022," according to Whatech.
Here are five key points:
1. By 2022, the market is expected to reach $4.6 billion.
2. As device manufacturers continue to launch next-generation robotic devices, systems and instruments, the market will expand.
3. The U.S. aging population has market growth, with more patients requiring medical devices.
4. Stryker's Mako orthopedic reconstruction surgical products are also paving the way for market growth, with MAKO yielding less patient bleeding, less postoperative pain and reduced readmission rates.
5. The study's authors noted, "Use of the robot with the orthopedic implant represents a key milestone in reconstructive surgery. Robots provide an opportunity to transform orthopedics."
More device news:
North America continues to dominate global neurosurgery market — 5 points
Amendia launches Ceres-C cervical interbody device: 4 key notes
Geisinger Health Plan exclusively covers SI-BONE's iFuse system for SI joint fusion: 5 things to know